Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Spire Healthcare ( (GB:SPI) ) has provided an update.
Spire Healthcare Group announced the purchase and cancellation of 50,000 of its ordinary shares as part of its share buyback programme, which was previously approved by shareholders. This transaction, conducted on the London Stock Exchange through Deutsche Numis, leaves the company with 402,851,824 shares in issue, maintaining its strategy to enhance shareholder value. The move signifies the company’s robust financial health and commitment to optimizing its capital structure, potentially impacting its market positioning positively by demonstrating confidence in its future prospects.
More about Spire Healthcare
Spire Healthcare is a leading independent healthcare group in the UK, operating 38 hospitals and over 50 clinics, medical centres, and consulting rooms across England, Wales, and Scotland. It offers a network of private GPs, occupational health services to over 800 corporate clients, and is the top private provider of knee and hip operations in the UK. The company also provides private and NHS mental health, musculoskeletal, and dermatological services under the Vita Health Group brand. Spire Healthcare is listed on the London Stock Exchange and is a part of the FTSE 250.
YTD Price Performance: 0.35%
Average Trading Volume: 526,026
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £907.9M
See more insights into SPI stock on TipRanks’ Stock Analysis page.